nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—OGDH—urine—polycystic ovary syndrome	0.0311	0.0891	CbGeAlD
Valproic Acid—Gastrointestinal tract irritation—Metformin—polycystic ovary syndrome	0.0135	0.0671	CcSEcCtD
Valproic Acid—Tooth abscess—Metformin—polycystic ovary syndrome	0.0115	0.0574	CcSEcCtD
Valproic Acid—Emotional distress—Metformin—polycystic ovary syndrome	0.0113	0.0564	CcSEcCtD
Valproic Acid—SLC22A8—urine—polycystic ovary syndrome	0.00942	0.027	CbGeAlD
Valproic Acid—Hypothermia—Metformin—polycystic ovary syndrome	0.00858	0.0427	CcSEcCtD
Valproic Acid—Body temperature decreased—Metformin—polycystic ovary syndrome	0.00858	0.0427	CcSEcCtD
Valproic Acid—CYP2C19—urine—polycystic ovary syndrome	0.0079	0.0226	CbGeAlD
Valproic Acid—UGT1A10—endocrine gland—polycystic ovary syndrome	0.00702	0.0201	CbGeAlD
Valproic Acid—OGDH—uterus—polycystic ovary syndrome	0.00678	0.0194	CbGeAlD
Valproic Acid—OGDH—pituitary gland—polycystic ovary syndrome	0.00666	0.0191	CbGeAlD
Valproic Acid—OGDH—adipose tissue—polycystic ovary syndrome	0.00663	0.019	CbGeAlD
Valproic Acid—ACADSB—adrenal cortex—polycystic ovary syndrome	0.00655	0.0187	CbGeAlD
Valproic Acid—UGT1A6—endocrine gland—polycystic ovary syndrome	0.00653	0.0187	CbGeAlD
Valproic Acid—CYP1A2—urine—polycystic ovary syndrome	0.00645	0.0185	CbGeAlD
Valproic Acid—Fungal infection—Metformin—polycystic ovary syndrome	0.00623	0.031	CcSEcCtD
Valproic Acid—CYP2C9—urine—polycystic ovary syndrome	0.00612	0.0175	CbGeAlD
Valproic Acid—HDAC9—uterus—polycystic ovary syndrome	0.00598	0.0171	CbGeAlD
Valproic Acid—OGDH—adrenal gland—polycystic ovary syndrome	0.00595	0.017	CbGeAlD
Valproic Acid—HDAC9—adipose tissue—polycystic ovary syndrome	0.00585	0.0167	CbGeAlD
Valproic Acid—ACADSB—endometrium—polycystic ovary syndrome	0.00585	0.0167	CbGeAlD
Valproic Acid—UGT1A8—endocrine gland—polycystic ovary syndrome	0.00555	0.0159	CbGeAlD
Valproic Acid—OGDH—female gonad—polycystic ovary syndrome	0.00555	0.0159	CbGeAlD
Valproic Acid—Contusion—Metformin—polycystic ovary syndrome	0.00552	0.0275	CcSEcCtD
Valproic Acid—Accidental injury—Metformin—polycystic ovary syndrome	0.00544	0.0271	CcSEcCtD
Valproic Acid—ACADSB—uterus—polycystic ovary syndrome	0.00539	0.0154	CbGeAlD
Valproic Acid—ACADSB—pituitary gland—polycystic ovary syndrome	0.00529	0.0151	CbGeAlD
Valproic Acid—ACADSB—adipose tissue—polycystic ovary syndrome	0.00527	0.0151	CbGeAlD
Valproic Acid—HDAC9—adrenal gland—polycystic ovary syndrome	0.00524	0.015	CbGeAlD
Valproic Acid—OGDH—endocrine gland—polycystic ovary syndrome	0.00516	0.0148	CbGeAlD
Valproic Acid—UGT1A3—endocrine gland—polycystic ovary syndrome	0.00495	0.0142	CbGeAlD
Valproic Acid—HDAC9—female gonad—polycystic ovary syndrome	0.00489	0.014	CbGeAlD
Valproic Acid—ACADSB—adrenal gland—polycystic ovary syndrome	0.00473	0.0135	CbGeAlD
Valproic Acid—CYP3A4—urine—polycystic ovary syndrome	0.00467	0.0134	CbGeAlD
Valproic Acid—UGT2B15—endocrine gland—polycystic ovary syndrome	0.00465	0.0133	CbGeAlD
Valproic Acid—ALDH5A1—adipose tissue—polycystic ovary syndrome	0.00464	0.0133	CbGeAlD
Valproic Acid—HDAC2—embryo—polycystic ovary syndrome	0.00453	0.013	CbGeAlD
Valproic Acid—ACADSB—female gonad—polycystic ovary syndrome	0.00441	0.0126	CbGeAlD
Valproic Acid—ACADSB—vagina—polycystic ovary syndrome	0.00438	0.0125	CbGeAlD
Valproic Acid—UGT1A4—endocrine gland—polycystic ovary syndrome	0.00421	0.012	CbGeAlD
Valproic Acid—ALDH5A1—adrenal gland—polycystic ovary syndrome	0.00416	0.0119	CbGeAlD
Valproic Acid—ACADSB—endocrine gland—polycystic ovary syndrome	0.0041	0.0117	CbGeAlD
Valproic Acid—Ear pain—Metformin—polycystic ovary syndrome	0.00409	0.0204	CcSEcCtD
Valproic Acid—ABAT—pituitary gland—polycystic ovary syndrome	0.00398	0.0114	CbGeAlD
Valproic Acid—ABAT—adipose tissue—polycystic ovary syndrome	0.00397	0.0114	CbGeAlD
Valproic Acid—ALDH5A1—female gonad—polycystic ovary syndrome	0.00388	0.0111	CbGeAlD
Valproic Acid—ALDH5A1—vagina—polycystic ovary syndrome	0.00386	0.011	CbGeAlD
Valproic Acid—Injury—Metformin—polycystic ovary syndrome	0.0038	0.0189	CcSEcCtD
Valproic Acid—ALDH5A1—endocrine gland—polycystic ovary syndrome	0.00361	0.0103	CbGeAlD
Valproic Acid—Lethargy—Metformin—polycystic ovary syndrome	0.00356	0.0177	CcSEcCtD
Valproic Acid—ABAT—adrenal gland—polycystic ovary syndrome	0.00356	0.0102	CbGeAlD
Valproic Acid—UGT1A9—endocrine gland—polycystic ovary syndrome	0.00352	0.0101	CbGeAlD
Valproic Acid—ABAT—female gonad—polycystic ovary syndrome	0.00332	0.0095	CbGeAlD
Valproic Acid—HDAC2—endometrium—polycystic ovary syndrome	0.00332	0.0095	CbGeAlD
Valproic Acid—ABAT—vagina—polycystic ovary syndrome	0.0033	0.00944	CbGeAlD
Valproic Acid—CYP2C18—vagina—polycystic ovary syndrome	0.00329	0.00943	CbGeAlD
Valproic Acid—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00319	0.0159	CcSEcCtD
Valproic Acid—Breast disorder—Metformin—polycystic ovary syndrome	0.00316	0.0157	CcSEcCtD
Valproic Acid—ABAT—endocrine gland—polycystic ovary syndrome	0.00309	0.00884	CbGeAlD
Valproic Acid—CYP2C18—endocrine gland—polycystic ovary syndrome	0.00308	0.00882	CbGeAlD
Valproic Acid—HDAC2—uterus—polycystic ovary syndrome	0.00306	0.00875	CbGeAlD
Valproic Acid—Influenza—Metformin—polycystic ovary syndrome	0.00302	0.015	CcSEcCtD
Valproic Acid—HDAC2—pituitary gland—polycystic ovary syndrome	0.003	0.00859	CbGeAlD
Valproic Acid—HDAC2—adipose tissue—polycystic ovary syndrome	0.00299	0.00856	CbGeAlD
Valproic Acid—Pancreatitis—Metformin—polycystic ovary syndrome	0.00296	0.0147	CcSEcCtD
Valproic Acid—SLC16A1—endometrium—polycystic ovary syndrome	0.00295	0.00844	CbGeAlD
Valproic Acid—Sweating increased—Metformin—polycystic ovary syndrome	0.00294	0.0146	CcSEcCtD
Valproic Acid—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00289	0.0144	CcSEcCtD
Valproic Acid—UGT2B7—endocrine gland—polycystic ovary syndrome	0.00284	0.00813	CbGeAlD
Valproic Acid—Neutropenia—Metformin—polycystic ovary syndrome	0.00282	0.0141	CcSEcCtD
Valproic Acid—SLC16A1—uterus—polycystic ovary syndrome	0.00272	0.00778	CbGeAlD
Valproic Acid—SLC22A7—endocrine gland—polycystic ovary syndrome	0.0027	0.00774	CbGeAlD
Valproic Acid—Drowsiness—Metformin—polycystic ovary syndrome	0.00269	0.0134	CcSEcCtD
Valproic Acid—HDAC2—adrenal gland—polycystic ovary syndrome	0.00268	0.00768	CbGeAlD
Valproic Acid—SLC16A1—pituitary gland—polycystic ovary syndrome	0.00267	0.00764	CbGeAlD
Valproic Acid—SLC16A1—adipose tissue—polycystic ovary syndrome	0.00266	0.0076	CbGeAlD
Valproic Acid—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00262	0.00749	CbGeAlD
Valproic Acid—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00255	0.0127	CcSEcCtD
Valproic Acid—HDAC2—female gonad—polycystic ovary syndrome	0.0025	0.00716	CbGeAlD
Valproic Acid—HDAC2—vagina—polycystic ovary syndrome	0.00248	0.00711	CbGeAlD
Valproic Acid—Bradycardia—Metformin—polycystic ovary syndrome	0.00246	0.0122	CcSEcCtD
Valproic Acid—Rhinitis—Metformin—polycystic ovary syndrome	0.00242	0.0121	CcSEcCtD
Valproic Acid—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0024	0.012	CcSEcCtD
Valproic Acid—SLC16A1—adrenal gland—polycystic ovary syndrome	0.00238	0.00682	CbGeAlD
Valproic Acid—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00238	0.0119	CcSEcCtD
Valproic Acid—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00237	0.0118	CcSEcCtD
Valproic Acid—HDAC2—endocrine gland—polycystic ovary syndrome	0.00232	0.00666	CbGeAlD
Valproic Acid—Eye disorder—Metformin—polycystic ovary syndrome	0.00226	0.0112	CcSEcCtD
Valproic Acid—SLC16A1—female gonad—polycystic ovary syndrome	0.00222	0.00636	CbGeAlD
Valproic Acid—Angiopathy—Metformin—polycystic ovary syndrome	0.00219	0.0109	CcSEcCtD
Valproic Acid—Immune system disorder—Metformin—polycystic ovary syndrome	0.00218	0.0109	CcSEcCtD
Valproic Acid—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00218	0.0108	CcSEcCtD
Valproic Acid—CYP2A6—vagina—polycystic ovary syndrome	0.00218	0.00623	CbGeAlD
Valproic Acid—Chills—Metformin—polycystic ovary syndrome	0.00217	0.0108	CcSEcCtD
Valproic Acid—Malnutrition—Metformin—polycystic ovary syndrome	0.0021	0.0105	CcSEcCtD
Valproic Acid—Flatulence—Metformin—polycystic ovary syndrome	0.00207	0.0103	CcSEcCtD
Valproic Acid—SLC16A1—endocrine gland—polycystic ovary syndrome	0.00207	0.00592	CbGeAlD
Valproic Acid—Dysgeusia—Metformin—polycystic ovary syndrome	0.00206	0.0103	CcSEcCtD
Valproic Acid—Muscle spasms—Metformin—polycystic ovary syndrome	0.00202	0.0101	CcSEcCtD
Valproic Acid—Vision blurred—Metformin—polycystic ovary syndrome	0.00198	0.00987	CcSEcCtD
Valproic Acid—Tremor—Metformin—polycystic ovary syndrome	0.00197	0.00981	CcSEcCtD
Valproic Acid—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00195	0.00972	CcSEcCtD
Valproic Acid—Malaise—Metformin—polycystic ovary syndrome	0.0019	0.00945	CcSEcCtD
Valproic Acid—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00189	0.0054	CbGeAlD
Valproic Acid—Palpitations—Metformin—polycystic ovary syndrome	0.00186	0.00926	CcSEcCtD
Valproic Acid—Hypertension—Metformin—polycystic ovary syndrome	0.00182	0.00904	CcSEcCtD
Valproic Acid—Myalgia—Metformin—polycystic ovary syndrome	0.00179	0.00892	CcSEcCtD
Valproic Acid—Chest pain—Metformin—polycystic ovary syndrome	0.00179	0.00892	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00178	0.00886	CcSEcCtD
Valproic Acid—Discomfort—Metformin—polycystic ovary syndrome	0.00177	0.00881	CcSEcCtD
Valproic Acid—Oedema—Metformin—polycystic ovary syndrome	0.00172	0.00855	CcSEcCtD
Valproic Acid—Infection—Metformin—polycystic ovary syndrome	0.00171	0.00849	CcSEcCtD
Valproic Acid—SLC22A5—endometrium—polycystic ovary syndrome	0.00168	0.00482	CbGeAlD
Valproic Acid—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00168	0.00838	CcSEcCtD
Valproic Acid—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00168	0.00837	CcSEcCtD
Valproic Acid—Skin disorder—Metformin—polycystic ovary syndrome	0.00167	0.0083	CcSEcCtD
Valproic Acid—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00166	0.00826	CcSEcCtD
Valproic Acid—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00164	0.00469	CbGeAlD
Valproic Acid—Anorexia—Metformin—polycystic ovary syndrome	0.00164	0.00815	CcSEcCtD
Valproic Acid—CYP2C8—endometrium—polycystic ovary syndrome	0.00163	0.00467	CbGeAlD
Valproic Acid—Hypotension—Metformin—polycystic ovary syndrome	0.0016	0.00799	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00156	0.00779	CcSEcCtD
Valproic Acid—Paraesthesia—Metformin—polycystic ovary syndrome	0.00154	0.00768	CcSEcCtD
Valproic Acid—Dyspnoea—Metformin—polycystic ovary syndrome	0.00153	0.00762	CcSEcCtD
Valproic Acid—Somnolence—Metformin—polycystic ovary syndrome	0.00153	0.0076	CcSEcCtD
Valproic Acid—SLC22A5—pituitary gland—polycystic ovary syndrome	0.00152	0.00436	CbGeAlD
Valproic Acid—SLC22A5—adipose tissue—polycystic ovary syndrome	0.00152	0.00434	CbGeAlD
Valproic Acid—Dyspepsia—Metformin—polycystic ovary syndrome	0.00151	0.00752	CcSEcCtD
Valproic Acid—Decreased appetite—Metformin—polycystic ovary syndrome	0.00149	0.00743	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00148	0.00738	CcSEcCtD
Valproic Acid—Fatigue—Metformin—polycystic ovary syndrome	0.00148	0.00737	CcSEcCtD
Valproic Acid—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00148	0.00422	CbGeAlD
Valproic Acid—Constipation—Metformin—polycystic ovary syndrome	0.00147	0.00731	CcSEcCtD
Valproic Acid—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00141	0.00704	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0014	0.00699	CcSEcCtD
Valproic Acid—CYP2C19—vagina—polycystic ovary syndrome	0.0014	0.00401	CbGeAlD
Valproic Acid—Urticaria—Metformin—polycystic ovary syndrome	0.00136	0.00679	CcSEcCtD
Valproic Acid—SLC22A5—adrenal gland—polycystic ovary syndrome	0.00136	0.0039	CbGeAlD
Valproic Acid—Abdominal pain—Metformin—polycystic ovary syndrome	0.00136	0.00676	CcSEcCtD
Valproic Acid—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00133	0.0038	CbGeAlD
Valproic Acid—PTGS1—endometrium—polycystic ovary syndrome	0.00132	0.00378	CbGeAlD
Valproic Acid—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00131	0.00375	CbGeAlD
Valproic Acid—SLC22A5—female gonad—polycystic ovary syndrome	0.00127	0.00363	CbGeAlD
Valproic Acid—SLC22A5—vagina—polycystic ovary syndrome	0.00126	0.00361	CbGeAlD
Valproic Acid—Asthenia—Metformin—polycystic ovary syndrome	0.00123	0.00613	CcSEcCtD
Valproic Acid—CYP2C8—vagina—polycystic ovary syndrome	0.00122	0.0035	CbGeAlD
Valproic Acid—PTGS1—uterus—polycystic ovary syndrome	0.00122	0.00349	CbGeAlD
Valproic Acid—Pruritus—Metformin—polycystic ovary syndrome	0.00121	0.00605	CcSEcCtD
Valproic Acid—PTGS1—pituitary gland—polycystic ovary syndrome	0.0012	0.00343	CbGeAlD
Valproic Acid—PTGS1—adipose tissue—polycystic ovary syndrome	0.00119	0.00341	CbGeAlD
Valproic Acid—CYP2B6—adrenal gland—polycystic ovary syndrome	0.00118	0.00338	CbGeAlD
Valproic Acid—Diarrhoea—Metformin—polycystic ovary syndrome	0.00117	0.00585	CcSEcCtD
Valproic Acid—CYP2C8—endocrine gland—polycystic ovary syndrome	0.00114	0.00327	CbGeAlD
Valproic Acid—Dizziness—Metformin—polycystic ovary syndrome	0.00114	0.00565	CcSEcCtD
Valproic Acid—CYP3A5—female gonad—polycystic ovary syndrome	0.00111	0.00318	CbGeAlD
Valproic Acid—CYP3A5—vagina—polycystic ovary syndrome	0.0011	0.00316	CbGeAlD
Valproic Acid—CYP2B6—vagina—polycystic ovary syndrome	0.0011	0.00314	CbGeAlD
Valproic Acid—Vomiting—Metformin—polycystic ovary syndrome	0.00109	0.00544	CcSEcCtD
Valproic Acid—Rash—Metformin—polycystic ovary syndrome	0.00108	0.00539	CcSEcCtD
Valproic Acid—Dermatitis—Metformin—polycystic ovary syndrome	0.00108	0.00538	CcSEcCtD
Valproic Acid—Headache—Metformin—polycystic ovary syndrome	0.00108	0.00536	CcSEcCtD
Valproic Acid—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00107	0.00306	CbGeAlD
Valproic Acid—PTGS1—adrenal gland—polycystic ovary syndrome	0.00107	0.00306	CbGeAlD
Valproic Acid—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00103	0.00295	CbGeAlD
Valproic Acid—CYP2B6—endocrine gland—polycystic ovary syndrome	0.00103	0.00293	CbGeAlD
Valproic Acid—Nausea—Metformin—polycystic ovary syndrome	0.00102	0.00508	CcSEcCtD
Valproic Acid—CYP2C9—endocrine gland—polycystic ovary syndrome	0.00102	0.00291	CbGeAlD
Valproic Acid—PTGS1—female gonad—polycystic ovary syndrome	0.000996	0.00285	CbGeAlD
Valproic Acid—PTGS1—vagina—polycystic ovary syndrome	0.00099	0.00284	CbGeAlD
Valproic Acid—PTGS1—endocrine gland—polycystic ovary syndrome	0.000927	0.00265	CbGeAlD
Valproic Acid—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000774	0.00222	CbGeAlD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.89e-05	8.65e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	3.87e-05	8.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	3.86e-05	8.58e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—POMC—polycystic ovary syndrome	3.86e-05	8.58e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	3.86e-05	8.58e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—NCOR1—polycystic ovary syndrome	3.86e-05	8.58e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—INS—polycystic ovary syndrome	3.84e-05	8.53e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.83e-05	8.52e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	3.83e-05	8.5e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.81e-05	8.47e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	3.8e-05	8.45e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—IL6—polycystic ovary syndrome	3.77e-05	8.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	3.76e-05	8.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP1A1—polycystic ovary syndrome	3.76e-05	8.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	3.75e-05	8.34e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	3.74e-05	8.31e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—INS—polycystic ovary syndrome	3.74e-05	8.31e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.72e-05	8.27e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.71e-05	8.24e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—SERPINE1—polycystic ovary syndrome	3.7e-05	8.22e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	3.69e-05	8.2e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.68e-05	8.17e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.66e-05	8.14e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	3.66e-05	8.13e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NRG1—polycystic ovary syndrome	3.65e-05	8.12e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	3.65e-05	8.11e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT2—polycystic ovary syndrome	3.61e-05	8.03e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	3.59e-05	7.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	3.59e-05	7.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.55e-05	7.89e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	3.52e-05	7.83e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.52e-05	7.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	3.51e-05	7.8e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—MTHFR—polycystic ovary syndrome	3.51e-05	7.8e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PPARG—polycystic ovary syndrome	3.49e-05	7.75e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	3.44e-05	7.65e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—POMC—polycystic ovary syndrome	3.44e-05	7.65e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—SERPINE1—polycystic ovary syndrome	3.43e-05	7.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	3.42e-05	7.61e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—INS—polycystic ovary syndrome	3.42e-05	7.61e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	3.41e-05	7.58e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	3.41e-05	7.58e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	3.39e-05	7.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	3.35e-05	7.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	3.34e-05	7.43e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	3.33e-05	7.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.31e-05	7.36e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	3.29e-05	7.32e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—TH—polycystic ovary syndrome	3.29e-05	7.31e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	3.29e-05	7.31e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PPARG—polycystic ovary syndrome	3.25e-05	7.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	3.24e-05	7.2e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.22e-05	7.15e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	3.21e-05	7.14e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—POMC—polycystic ovary syndrome	3.21e-05	7.13e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	3.2e-05	7.12e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	3.2e-05	7.11e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—INS—polycystic ovary syndrome	3.19e-05	7.09e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	3.16e-05	7.02e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.14e-05	6.98e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	3.14e-05	6.97e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.13e-05	6.96e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.13e-05	6.95e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.13e-05	6.95e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	3.12e-05	6.93e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—TH—polycystic ovary syndrome	3.11e-05	6.91e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	3.09e-05	6.86e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	3.07e-05	6.82e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—LEP—polycystic ovary syndrome	3.06e-05	6.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	3.05e-05	6.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	3.05e-05	6.79e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	3.05e-05	6.78e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.03e-05	6.74e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	3.02e-05	6.72e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.02e-05	6.71e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	3.01e-05	6.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	2.99e-05	6.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	2.98e-05	6.63e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	2.97e-05	6.61e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	2.95e-05	6.55e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	2.9e-05	6.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.89e-05	6.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	2.89e-05	6.42e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	2.88e-05	6.4e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.86e-05	6.36e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	2.84e-05	6.32e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	2.84e-05	6.32e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	2.83e-05	6.3e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	2.8e-05	6.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—INS—polycystic ovary syndrome	2.79e-05	6.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	2.78e-05	6.19e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	2.78e-05	6.19e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	2.77e-05	6.16e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	2.77e-05	6.15e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	2.74e-05	6.08e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.73e-05	6.07e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	2.73e-05	6.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	2.72e-05	6.05e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—INS—polycystic ovary syndrome	2.71e-05	6.03e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	2.68e-05	5.97e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	2.67e-05	5.94e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	2.66e-05	5.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.66e-05	5.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	2.64e-05	5.87e-05	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL6—polycystic ovary syndrome	2.64e-05	5.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	2.64e-05	5.86e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—POMC—polycystic ovary syndrome	2.63e-05	5.85e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.62e-05	5.83e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.62e-05	5.82e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—INS—polycystic ovary syndrome	2.62e-05	5.82e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.61e-05	5.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.58e-05	5.73e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	2.58e-05	5.73e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	2.56e-05	5.68e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	2.54e-05	5.64e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.53e-05	5.63e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.53e-05	5.62e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—TH—polycystic ovary syndrome	2.51e-05	5.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	2.49e-05	5.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	2.48e-05	5.52e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.48e-05	5.52e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	2.45e-05	5.46e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—TH—polycystic ovary syndrome	2.45e-05	5.45e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.45e-05	5.44e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	2.44e-05	5.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	2.43e-05	5.39e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	2.42e-05	5.39e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	2.42e-05	5.37e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.4e-05	5.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	2.39e-05	5.3e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	2.39e-05	5.3e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	2.38e-05	5.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.37e-05	5.27e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.37e-05	5.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	2.36e-05	5.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	2.35e-05	5.22e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.34e-05	5.2e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.33e-05	5.17e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	2.29e-05	5.1e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	2.29e-05	5.1e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	2.26e-05	5.03e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	2.26e-05	5.02e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.25e-05	5.01e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	2.25e-05	5e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	2.24e-05	4.99e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	2.23e-05	4.95e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	2.22e-05	4.93e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—INS—polycystic ovary syndrome	2.2e-05	4.9e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	2.19e-05	4.87e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	2.18e-05	4.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.16e-05	4.81e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	2.15e-05	4.78e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	2.14e-05	4.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.13e-05	4.74e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—TH—polycystic ovary syndrome	2.12e-05	4.72e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.11e-05	4.69e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2.07e-05	4.61e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	2.07e-05	4.59e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	2.05e-05	4.55e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	2.03e-05	4.51e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.01e-05	4.48e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	2.01e-05	4.46e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	2e-05	4.45e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	2e-05	4.44e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	1.95e-05	4.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	1.94e-05	4.32e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	1.94e-05	4.3e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	1.91e-05	4.24e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.9e-05	4.21e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.86e-05	4.13e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	1.85e-05	4.11e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.85e-05	4.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.84e-05	4.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.84e-05	4.08e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.84e-05	4.08e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	1.83e-05	4.07e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.82e-05	4.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	1.81e-05	4.02e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—POMC—polycystic ovary syndrome	1.81e-05	4.02e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—INS—polycystic ovary syndrome	1.8e-05	4e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.8e-05	3.99e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.74e-05	3.86e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.73e-05	3.85e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.73e-05	3.85e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	1.73e-05	3.85e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	1.73e-05	3.85e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—TH—polycystic ovary syndrome	1.73e-05	3.84e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	1.72e-05	3.83e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	1.71e-05	3.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.71e-05	3.79e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—INS—polycystic ovary syndrome	1.7e-05	3.78e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	1.69e-05	3.75e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	1.68e-05	3.74e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.65e-05	3.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	1.65e-05	3.67e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—polycystic ovary syndrome	1.63e-05	3.63e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.6e-05	3.56e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	1.58e-05	3.51e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	1.57e-05	3.48e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.55e-05	3.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.55e-05	3.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.49e-05	3.32e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—TH—polycystic ovary syndrome	1.48e-05	3.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.47e-05	3.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	1.46e-05	3.24e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.44e-05	3.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.44e-05	3.19e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.42e-05	3.15e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.41e-05	3.14e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	1.4e-05	3.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.4e-05	3.11e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	1.38e-05	3.07e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—INS—polycystic ovary syndrome	1.37e-05	3.05e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	1.37e-05	3.04e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.35e-05	3e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	1.35e-05	3e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.34e-05	2.99e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—INS—polycystic ovary syndrome	1.34e-05	2.98e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.34e-05	2.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.32e-05	2.93e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	1.3e-05	2.9e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	1.27e-05	2.83e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	1.21e-05	2.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.19e-05	2.64e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	1.18e-05	2.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	1.17e-05	2.59e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—INS—polycystic ovary syndrome	1.16e-05	2.58e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.15e-05	2.55e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—polycystic ovary syndrome	1.14e-05	2.54e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.14e-05	2.53e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.11e-05	2.46e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.09e-05	2.42e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	1.06e-05	2.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.04e-05	2.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	1.04e-05	2.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—INS—polycystic ovary syndrome	1.04e-05	2.3e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.02e-05	2.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	9.63e-06	2.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	9.5e-06	2.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—INS—polycystic ovary syndrome	9.45e-06	2.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.31e-06	2.07e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	8.87e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8.4e-06	1.87e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	8.23e-06	1.83e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	8.12e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—INS—polycystic ovary syndrome	8.07e-06	1.79e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	7.84e-06	1.74e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.35e-06	1.41e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.27e-06	1.39e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.23e-06	1.39e-05	CbGpPWpGaD
